KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Liabilities from Discontinued Operations: 2013-2017

Historic Liabilities from Discontinued Operations for Teva Pharmaceutical Industries (TEVA) over the last 3 years, with Dec 2017 value amounting to $38.0 million.

  • Teva Pharmaceutical Industries' Liabilities from Discontinued Operations fell 67.24% to $38.0 million in Q4 2017 from the same period last year, while for Dec 2017 it was $38.0 million, marking a year-over-year decrease of 67.24%. This contributed to the annual value of $38.0 million for FY2017, which is 67.24% down from last year.
  • According to the latest figures from FY2017, Teva Pharmaceutical Industries' Liabilities from Discontinued Operations is $38.0 million, which was down 67.24% from $116.0 million recorded in FY2016.
  • Teva Pharmaceutical Industries' 5-year Liabilities from Discontinued Operations high stood at $246.6 million for FY2013, and its period low was $38.0 million during FY2017.
  • For the 2-year period, Teva Pharmaceutical Industries' Liabilities from Discontinued Operations averaged around $77.0 million, with its median value being $77.0 million (2016).
  • Data for Teva Pharmaceutical Industries' Liabilities from Discontinued Operations shows a maximum YoY crashed of 67.24% (in 2017) over the last 5 years.
  • Over the past 3 years, Teva Pharmaceutical Industries' Liabilities from Discontinued Operations (Yearly) stood at $246.6 million in 2013, then reached $116.0 million in 2016, then slumped by 67.24% to $38.0 million in 2017.